Enveric Biosciences Inc vs Seagate Technology Holdings PLC — how do they compare? Enveric Biosciences Inc trades at $1.48 (market cap $6.80M), while Seagate Technology Holdings PLC trades at $787.6 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 25910.3× Enveric Biosciences Inc's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | STX | |
|---|---|---|
Market Cap | $6.80M | $176.19B |
Volume | 64,867 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $10.80 | $1.09K |
52-Week Low | $1.27 | $211.63 |
Typical Hold Time | 14 Days | — |
Enterprise Value | -$1.49M | $178.34B |
Dividend Yield | — | 0.38% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
Seagate Technology (STX) trades at $780.39, down 3.34% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamental performance with Q2 2026 EPS beating expectations at $5.71 versus $5.10, and maintains robust profitability with 26.11% net margin and 371.53% ROE. Technical indicators signal bearish momentum with price below key pivot points, though RSI suggests potential oversold conditions at 24.89.
Despite near-term competitive pressures, Seagate's dominant position in AI storage and strong earnings trajectory support long-term growth. The consensus price target of $1,130 represents 45% upside potential, but investors face risks from pricing pressure and market share erosion as Toshiba expands capacity in 2027.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →